These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model. Bekerman E; Yant SR; VanderVeen L; Hansen D; Lu B; Rowe W; Wang K; Callebaut C J Clin Invest; 2023 Aug; 133(16):. PubMed ID: 37384413 [TBL] [Abstract][Full Text] [Related]
3. Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Dzinamarira T; Almehmadi M; Alsaiari AA; Allahyani M; Aljuaid A; Alsharif A; Khan A; Kamal M; Rabaan AA; Alfaraj AH; AlShehail BM; Alotaibi N; AlShehail SM; Imran M Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374245 [TBL] [Abstract][Full Text] [Related]
4. Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent. Subramanian R; Tang J; Zheng J; Lu B; Wang K; Yant SR; Stepan GJ; Mulato A; Yu H; Schroeder S; Shaik N; Singh R; Wolckenhauer S; Chester A; Tse WC; Chiu A; Rhee M; Cihlar T; Rowe W; Smith BJ Mol Pharm; 2023 Dec; 20(12):6213-6225. PubMed ID: 37917742 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, Disposition, and Biotransformation of [ Weber E; Subramanian R; Rowe W; Graupe M; Ling J; Shen G; Begley R; Sager J; Wolckenhauer S; Rhee M; Palaparthy R; Singh R Clin Pharmacokinet; 2024 Feb; 63(2):241-253. PubMed ID: 38236562 [TBL] [Abstract][Full Text] [Related]
7. Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host. Schmidt F; Keele BF; Del Prete GQ; Voronin D; Fennessey CM; Soll S; Kane M; Raymond A; Gifford RJ; KewalRamani V; Lifson JD; Bieniasz PD; Hatziioannou T Proc Natl Acad Sci U S A; 2019 May; 116(21):10504-10509. PubMed ID: 31048506 [TBL] [Abstract][Full Text] [Related]
8. Lenacapavir: A novel injectable HIV-1 capsid inhibitor. Hitchcock AM; Kufel WD; Dwyer KAM; Sidman EF Int J Antimicrob Agents; 2024 Jan; 63(1):107009. PubMed ID: 37844807 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial. Ogbuagu O; Segal-Maurer S; Ratanasuwan W; Avihingsanon A; Brinson C; Workowski K; Antinori A; Yazdanpanah Y; Trottier B; Wang H; Margot N; Dvory-Sobol H; Rhee MS; Baeten JM; Molina JM; Lancet HIV; 2023 Aug; 10(8):e497-e505. PubMed ID: 37451297 [TBL] [Abstract][Full Text] [Related]
10. Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV in Nonhuman Primate Models of AIDS. Swanstrom AE; Jacques A; Del Prete GQ; Bieniasz P; Hatziioannou T; Gorelick R; Lifson JD AIDS Res Hum Retroviruses; 2019 May; 35(5):473-476. PubMed ID: 30632394 [TBL] [Abstract][Full Text] [Related]
11. Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes. Margot N; Ram R; Rhee M; Callebaut C Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288639 [TBL] [Abstract][Full Text] [Related]
12. Lenacapavir: a first-in-class HIV-1 capsid inhibitor. Dvory-Sobol H; Shaik N; Callebaut C; Rhee MS Curr Opin HIV AIDS; 2022 Jan; 17(1):15-21. PubMed ID: 34871187 [TBL] [Abstract][Full Text] [Related]
13. A macaque model of HIV-1 infection. Hatziioannou T; Ambrose Z; Chung NP; Piatak M; Yuan F; Trubey CM; Coalter V; Kiser R; Schneider D; Smedley J; Pung R; Gathuka M; Estes JD; Veazey RS; KewalRamani VN; Lifson JD; Bieniasz PD Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4425-9. PubMed ID: 19255423 [TBL] [Abstract][Full Text] [Related]
15. Lenacapavir: A first-in-class capsid inhibitor for the treatment of highly treatment-resistant HIV. Prather C; Lee A; Yen C Am J Health Syst Pharm; 2023 Dec; 80(24):1774-1780. PubMed ID: 37767713 [TBL] [Abstract][Full Text] [Related]
16. Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV. Tailor MW; Chahine EB; Koren D; Sherman EM Ann Pharmacother; 2024 Feb; 58(2):185-195. PubMed ID: 37138515 [TBL] [Abstract][Full Text] [Related]